Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

David E Kandzari¹, Raymond R Townsend², George Bakris³, Jan Basile⁴, Michael J Bloch⁵, Debbie L Cohen², Cara East^{6

7}, Keith C Ferdinand⁸, Naomi Fisher⁹, Ajay Kirtane¹⁰, David P Lee¹¹, Gary Puckrein¹², Florian Rader¹³, Joseph A Vassalotti¹⁴, Michael A Weber¹⁵, Kerry Willis¹⁶, Eric Secemsky¹⁷

Affiliations

¹ Interventional Cardiology, Piedmont Heart Institute, Atlanta, Georgia, USA.
² Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Hypertension, University of Chicago Medicine, Chicago, Illinois, USA.
⁴ Cardiology, Medical University of South Carolina and Ralph H. Johnson VA Medical Center to Medical University of South Carolina, Charleston, South Carolina, USA.
⁵ Vascular Care, Renown Institute for Heart and Vascular Health, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
⁶ Cardiology, Baylor Heart & Vascular Hospital, Dallas, Texas, USA.
⁷ Vascular Intervention, Soltero CV Research Center, Texas A&M College of Medicine.
⁸ Preventive Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
⁹ Hypertension, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
¹⁰ Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York, USA.
¹¹ Interventional Cardiology, Stanford University, Stanford, California, USA.
¹² The National Minority Quality Forum, Washington, District of Columbia, USA.
¹³ Hypertension Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
¹⁴ Clinical Professor, Icahn School of Medicine at Mount Sinai, National Kidney Foundation, New York, New York, USA.
¹⁵ Cardiovascular Medicine, SUNY Downstate Medical Center, New York, New York, USA.
¹⁶ National Kidney Foundation, New York, New York, USA.
¹⁷ Vascular Intervention, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

PMID: 34343406
DOI: 10.1002/ccd.29884

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

David E Kandzari et al. Catheter Cardiovasc Interv. 2021 Sep.

. 2021 Sep;98(3):416-426.

doi: 10.1002/ccd.29884. Epub 2021 Aug 3.

Authors

Affiliations

¹ Interventional Cardiology, Piedmont Heart Institute, Atlanta, Georgia, USA.
² Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Hypertension, University of Chicago Medicine, Chicago, Illinois, USA.
⁴ Cardiology, Medical University of South Carolina and Ralph H. Johnson VA Medical Center to Medical University of South Carolina, Charleston, South Carolina, USA.
⁵ Vascular Care, Renown Institute for Heart and Vascular Health, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
⁶ Cardiology, Baylor Heart & Vascular Hospital, Dallas, Texas, USA.
⁷ Vascular Intervention, Soltero CV Research Center, Texas A&M College of Medicine.
⁸ Preventive Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
⁹ Hypertension, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
¹⁰ Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York, USA.
¹¹ Interventional Cardiology, Stanford University, Stanford, California, USA.
¹² The National Minority Quality Forum, Washington, District of Columbia, USA.
¹³ Hypertension Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
¹⁴ Clinical Professor, Icahn School of Medicine at Mount Sinai, National Kidney Foundation, New York, New York, USA.
¹⁵ Cardiovascular Medicine, SUNY Downstate Medical Center, New York, New York, USA.
¹⁶ National Kidney Foundation, New York, New York, USA.
¹⁷ Vascular Intervention, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

PMID: 34343406
DOI: 10.1002/ccd.29884

No abstract available

Keywords: blood pressure; cardiovascular risk; device-based hypertension therapies; hypertension; renal denervation.

PubMed Disclaimer

References

REFERENCES

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
1. Muntner P, Carey RM, Gidding S, et al. Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline. J Am Coll Cardiol. 2018;71:109-118.
1. Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324:1190-1200.
1. Lauder L, Azizi M, Kirtane AJ, Böhm M, Mahfoud F. Device-based therapies for arterial hypertension. Nat Rev Cardiol. 2020;17:614-628.
1. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

Affiliations

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

Authors

Affiliations

References

REFERENCES

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical